MHT linked to dementia risk, even with short-term use: study
But US doctors stressed the findings should not infer causality or inform shared decision-making.
Editor’s note: The headline for this article has been updated. See response to comment below.
Use of menopausal hormone therapy is linked to an elevated risk of dementia and Alzheimer’s disease, regardless of duration of use or the age at which women started treatment, a large study shows.
Danish clinicians report that women exposed to oestrogen-progestin therapy were 24% more likely to develop all-cause dementia compared to never users.
Their results also suggest a 21% and 22% higher risk of late onset dementia and Alzheimer’s disease, respectively, among those who had used menopausal hormone therapy (MHT).
